CERO THERAPEUTICS HOLDINGS, INC. Accrued Liabilities, Current
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Accrued Liabilities, Current of $485.01 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $485.01K.
- 2026-03-31: Accrued Liabilities, Current $500.79K.
- 2025-12-31: Accrued Liabilities, Current $363.81K.
- 2025-09-30: Accrued Liabilities, Current $340.69K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $485.01K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $500.79K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $363.81K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $340.69K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $365.06K 10-Q · filed 2025-08-22 |
| 2025-03-31 | $469.66K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.91M 10-K · filed 2026-04-15 |
| 2024-09-30 | $1.69M 10-Q/A · filed 2024-11-20 |
| 2024-06-30 | $1.16M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $294.34K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $144.63K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |